George Jr-yuan Chiou, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Eye | 35 | 2004 | 710 | 2.310 |
Why?
|
| Interleukin-1 | 18 | 2006 | 1249 | 1.780 |
Why?
|
| Rabbits | 78 | 2011 | 4773 | 1.360 |
Why?
|
| Ocular Hypertension | 16 | 2004 | 206 | 1.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 19 | 2006 | 2282 | 1.030 |
Why?
|
| Retina | 18 | 2004 | 2635 | 0.970 |
Why?
|
| Choroidal Neovascularization | 4 | 2011 | 357 | 0.930 |
Why?
|
| Intraocular Pressure | 28 | 2004 | 1288 | 0.920 |
Why?
|
| Uveitis | 10 | 2000 | 393 | 0.880 |
Why?
|
| Pyridazines | 10 | 2006 | 200 | 0.860 |
Why?
|
| Dopamine Antagonists | 10 | 2001 | 288 | 0.830 |
Why?
|
| Nitric Oxide Donors | 5 | 2003 | 125 | 0.790 |
Why?
|
| Ophthalmic Solutions | 22 | 2005 | 304 | 0.640 |
Why?
|
| Flavonoids | 5 | 2004 | 445 | 0.600 |
Why?
|
| Timolol | 13 | 1995 | 51 | 0.590 |
Why?
|
| Regional Blood Flow | 23 | 2005 | 1490 | 0.570 |
Why?
|
| Ischemia | 12 | 2004 | 1893 | 0.570 |
Why?
|
| Nitric Oxide | 7 | 2003 | 2141 | 0.570 |
Why?
|
| Lacrimal Apparatus | 3 | 2003 | 223 | 0.550 |
Why?
|
| Uveitis, Posterior | 5 | 1998 | 45 | 0.520 |
Why?
|
| Retinal Artery | 6 | 2004 | 109 | 0.520 |
Why?
|
| Retinal Vessels | 13 | 2001 | 836 | 0.510 |
Why?
|
| Nitric Oxide Synthase | 5 | 2003 | 908 | 0.430 |
Why?
|
| Drugs, Chinese Herbal | 5 | 1997 | 151 | 0.430 |
Why?
|
| Ciliary Body | 9 | 2003 | 166 | 0.420 |
Why?
|
| Rats | 35 | 2007 | 23711 | 0.390 |
Why?
|
| Prednisolone | 9 | 2006 | 327 | 0.380 |
Why?
|
| Choroid | 9 | 2011 | 349 | 0.370 |
Why?
|
| Quercetin | 1 | 2011 | 97 | 0.360 |
Why?
|
| Animals | 115 | 2011 | 167963 | 0.350 |
Why?
|
| Cornea | 7 | 2000 | 1326 | 0.350 |
Why?
|
| Macular Degeneration | 3 | 2011 | 1002 | 0.340 |
Why?
|
| Endophthalmitis | 6 | 1996 | 257 | 0.320 |
Why?
|
| Gallic Acid | 3 | 1997 | 24 | 0.320 |
Why?
|
| Isoflavones | 2 | 1999 | 136 | 0.300 |
Why?
|
| Rats, Long-Evans | 7 | 2004 | 378 | 0.300 |
Why?
|
| Ciliary Arteries | 3 | 2004 | 19 | 0.290 |
Why?
|
| Vasodilator Agents | 3 | 1999 | 978 | 0.290 |
Why?
|
| Conjunctiva | 4 | 1998 | 479 | 0.290 |
Why?
|
| Absorption | 10 | 2005 | 243 | 0.290 |
Why?
|
| Retinal Artery Occlusion | 4 | 1997 | 77 | 0.290 |
Why?
|
| Antioxidants | 2 | 2011 | 1667 | 0.290 |
Why?
|
| Apigenin | 1 | 2006 | 17 | 0.280 |
Why?
|
| Insulin | 8 | 2005 | 6597 | 0.280 |
Why?
|
| Electroretinography | 10 | 2004 | 517 | 0.270 |
Why?
|
| Alkaloids | 4 | 1996 | 194 | 0.270 |
Why?
|
| Glucagon | 4 | 1995 | 532 | 0.270 |
Why?
|
| Coumarins | 4 | 1998 | 119 | 0.260 |
Why?
|
| Blood Flow Velocity | 7 | 1996 | 1377 | 0.260 |
Why?
|
| Imines | 4 | 1999 | 34 | 0.260 |
Why?
|
| Thiazines | 4 | 1999 | 37 | 0.260 |
Why?
|
| Arginine | 3 | 2001 | 934 | 0.260 |
Why?
|
| Haloperidol | 6 | 1993 | 389 | 0.260 |
Why?
|
| Lipoxygenase Inhibitors | 5 | 1991 | 93 | 0.250 |
Why?
|
| Pyrazines | 2 | 2007 | 1199 | 0.240 |
Why?
|
| Isoflurophate | 2 | 1995 | 28 | 0.240 |
Why?
|
| Melatonin | 5 | 1993 | 668 | 0.240 |
Why?
|
| Calcium Channel Blockers | 3 | 1997 | 694 | 0.240 |
Why?
|
| Hydroxides | 1 | 2004 | 46 | 0.240 |
Why?
|
| Crystallins | 7 | 1995 | 75 | 0.240 |
Why?
|
| Glaucoma | 7 | 1995 | 1182 | 0.240 |
Why?
|
| Flavones | 1 | 2004 | 68 | 0.240 |
Why?
|
| Acridines | 3 | 1999 | 19 | 0.230 |
Why?
|
| Nitro Compounds | 2 | 2003 | 74 | 0.230 |
Why?
|
| Cyclic GMP | 2 | 2002 | 395 | 0.230 |
Why?
|
| Pyrazoles | 6 | 2003 | 1999 | 0.230 |
Why?
|
| Endothelium, Vascular | 2 | 2007 | 4433 | 0.230 |
Why?
|
| Fibroblasts | 8 | 2000 | 4090 | 0.230 |
Why?
|
| Uvea | 3 | 1995 | 30 | 0.220 |
Why?
|
| Ocular Hypotension | 2 | 1995 | 23 | 0.220 |
Why?
|
| Rats, Sprague-Dawley | 15 | 2000 | 8158 | 0.210 |
Why?
|
| Trabeculectomy | 2 | 1995 | 174 | 0.210 |
Why?
|
| Eye Diseases | 3 | 2001 | 651 | 0.210 |
Why?
|
| Rats, Inbred BN | 3 | 2007 | 231 | 0.210 |
Why?
|
| Fluorescein Angiography | 4 | 2011 | 1045 | 0.200 |
Why?
|
| Canavanine | 1 | 2001 | 14 | 0.190 |
Why?
|
| Droperidol | 1 | 2001 | 21 | 0.190 |
Why?
|
| Metoclopramide | 1 | 2001 | 51 | 0.190 |
Why?
|
| Administration, Topical | 9 | 1996 | 697 | 0.190 |
Why?
|
| Polyethylene Glycols | 8 | 1995 | 1189 | 0.190 |
Why?
|
| Accommodation, Ocular | 1 | 2001 | 47 | 0.180 |
Why?
|
| Indomethacin | 3 | 1991 | 326 | 0.180 |
Why?
|
| Carbachol | 1 | 2001 | 223 | 0.180 |
Why?
|
| Hydrazines | 3 | 1998 | 224 | 0.180 |
Why?
|
| Iris | 6 | 2003 | 231 | 0.180 |
Why?
|
| Endotoxins | 4 | 1996 | 521 | 0.180 |
Why?
|
| Muscle, Smooth | 2 | 2001 | 924 | 0.170 |
Why?
|
| Blood Glucose | 9 | 2005 | 6381 | 0.170 |
Why?
|
| Propanolamines | 2 | 1995 | 162 | 0.160 |
Why?
|
| Endothelin-1 | 1 | 2001 | 302 | 0.160 |
Why?
|
| Domperidone | 3 | 1992 | 24 | 0.160 |
Why?
|
| Injections, Intraperitoneal | 4 | 2007 | 412 | 0.160 |
Why?
|
| Eye Proteins | 1 | 2002 | 633 | 0.160 |
Why?
|
| Quinolines | 3 | 1991 | 759 | 0.160 |
Why?
|
| Instillation, Drug | 4 | 2004 | 32 | 0.160 |
Why?
|
| Echo-Planar Imaging | 1 | 2003 | 657 | 0.160 |
Why?
|
| Dry Eye Syndromes | 1 | 2003 | 385 | 0.160 |
Why?
|
| Myopia | 1 | 2001 | 245 | 0.150 |
Why?
|
| Oxymetazoline | 1 | 1997 | 5 | 0.150 |
Why?
|
| Hydroxyquinolines | 2 | 1989 | 17 | 0.150 |
Why?
|
| Disease Models, Animal | 13 | 2007 | 18137 | 0.140 |
Why?
|
| Cells, Cultured | 11 | 2007 | 18957 | 0.140 |
Why?
|
| Reperfusion Injury | 1 | 2004 | 1023 | 0.140 |
Why?
|
| Nitroso Compounds | 1 | 1997 | 71 | 0.140 |
Why?
|
| Dopamine Agents | 3 | 1993 | 189 | 0.140 |
Why?
|
| Oxadiazoles | 1 | 1997 | 94 | 0.140 |
Why?
|
| Microspheres | 5 | 2004 | 787 | 0.140 |
Why?
|
| Trifluperidol | 3 | 1992 | 3 | 0.140 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 1997 | 178 | 0.140 |
Why?
|
| Cell Proliferation | 3 | 2007 | 10446 | 0.140 |
Why?
|
| Chemotaxis, Leukocyte | 3 | 1995 | 663 | 0.140 |
Why?
|
| Recovery of Function | 2 | 2004 | 2985 | 0.140 |
Why?
|
| Blood-Aqueous Barrier | 1 | 1996 | 7 | 0.130 |
Why?
|
| Hypoglycemia | 3 | 1995 | 888 | 0.130 |
Why?
|
| Benzylisoquinolines | 1 | 1996 | 15 | 0.130 |
Why?
|
| Dark Adaptation | 5 | 2000 | 221 | 0.130 |
Why?
|
| Cell Division | 8 | 2000 | 4463 | 0.130 |
Why?
|
| Conjunctivitis | 1 | 1997 | 155 | 0.130 |
Why?
|
| Hyperemia | 1 | 1997 | 221 | 0.130 |
Why?
|
| Hesperidin | 1 | 1996 | 18 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 12 | 2003 | 10827 | 0.130 |
Why?
|
| Carotenoids | 1 | 1999 | 620 | 0.130 |
Why?
|
| Umbilical Veins | 2 | 2007 | 426 | 0.130 |
Why?
|
| Mydriatics | 1 | 1996 | 67 | 0.130 |
Why?
|
| Enzyme Inhibitors | 3 | 2002 | 3726 | 0.130 |
Why?
|
| Butanones | 1 | 1995 | 28 | 0.120 |
Why?
|
| Receptors, Interleukin-1 | 3 | 2003 | 261 | 0.120 |
Why?
|
| Peptides | 3 | 1994 | 4354 | 0.120 |
Why?
|
| Cattle | 4 | 2006 | 3847 | 0.120 |
Why?
|
| Cell Movement | 1 | 2006 | 5206 | 0.120 |
Why?
|
| Laser Coagulation | 2 | 2007 | 329 | 0.120 |
Why?
|
| Glutathione | 1 | 1997 | 582 | 0.120 |
Why?
|
| Adrenergic beta-Antagonists | 3 | 1995 | 1259 | 0.120 |
Why?
|
| Radioimmunoassay | 5 | 1993 | 866 | 0.120 |
Why?
|
| Artifacts | 1 | 2003 | 1898 | 0.120 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 1997 | 1485 | 0.110 |
Why?
|
| Cholinergic Antagonists | 1 | 1995 | 164 | 0.110 |
Why?
|
| Parasympatholytics | 1 | 1994 | 89 | 0.110 |
Why?
|
| Endothelial Cells | 1 | 2006 | 3539 | 0.110 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2007 | 3201 | 0.110 |
Why?
|
| Wound Healing | 2 | 1995 | 2788 | 0.110 |
Why?
|
| Structure-Activity Relationship | 4 | 2004 | 3084 | 0.110 |
Why?
|
| Periodicals as Topic | 1 | 2004 | 1469 | 0.110 |
Why?
|
| Glaucoma, Open-Angle | 2 | 1994 | 734 | 0.110 |
Why?
|
| Injections, Intravenous | 6 | 1993 | 1385 | 0.110 |
Why?
|
| Monoterpenes | 1 | 1993 | 22 | 0.110 |
Why?
|
| Neuroblastoma | 2 | 1995 | 1252 | 0.110 |
Why?
|
| Image Enhancement | 2 | 2005 | 2881 | 0.110 |
Why?
|
| Menthol | 1 | 1993 | 26 | 0.110 |
Why?
|
| Female | 59 | 2005 | 391270 | 0.110 |
Why?
|
| Endorphins | 1 | 1993 | 74 | 0.110 |
Why?
|
| Flavanones | 1 | 1993 | 74 | 0.110 |
Why?
|
| Enkephalin, Leucine | 1 | 1992 | 16 | 0.110 |
Why?
|
| Enkephalin, Methionine | 1 | 1992 | 26 | 0.100 |
Why?
|
| Dog Diseases | 2 | 1991 | 141 | 0.100 |
Why?
|
| Triterpenes | 1 | 1993 | 81 | 0.100 |
Why?
|
| Ketanserin | 1 | 1992 | 24 | 0.100 |
Why?
|
| Chalcone | 1 | 1992 | 10 | 0.100 |
Why?
|
| Sorbitol | 1 | 1992 | 56 | 0.100 |
Why?
|
| Enkephalins | 2 | 1993 | 139 | 0.100 |
Why?
|
| Bromocriptine | 1 | 1992 | 93 | 0.100 |
Why?
|
| Hemolysis | 1 | 1994 | 423 | 0.100 |
Why?
|
| Iodates | 1 | 2011 | 2 | 0.100 |
Why?
|
| Sodium Azide | 1 | 2011 | 24 | 0.100 |
Why?
|
| Uveitis, Anterior | 1 | 1992 | 102 | 0.090 |
Why?
|
| beta-Endorphin | 1 | 1991 | 43 | 0.090 |
Why?
|
| Stereoisomerism | 5 | 2003 | 617 | 0.090 |
Why?
|
| Catecholamines | 2 | 1989 | 385 | 0.090 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2003 | 514 | 0.090 |
Why?
|
| Complement System Proteins | 1 | 1994 | 782 | 0.090 |
Why?
|
| Anticoagulants | 2 | 1997 | 4897 | 0.090 |
Why?
|
| Calcitonin | 1 | 1992 | 330 | 0.090 |
Why?
|
| DNA | 5 | 2000 | 7233 | 0.090 |
Why?
|
| Plant Extracts | 1 | 1994 | 496 | 0.090 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 1994 | 1112 | 0.090 |
Why?
|
| Gastrointestinal Agents | 1 | 1995 | 509 | 0.090 |
Why?
|
| Receptors, Adrenergic | 1 | 1989 | 155 | 0.080 |
Why?
|
| Tetrahydronaphthalenes | 1 | 1989 | 86 | 0.080 |
Why?
|
| Calcium | 3 | 1997 | 5725 | 0.080 |
Why?
|
| RNA | 2 | 1998 | 2722 | 0.080 |
Why?
|
| Fluorophotometry | 3 | 1996 | 40 | 0.080 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2003 | 4048 | 0.080 |
Why?
|
| Prostaglandins | 2 | 1994 | 398 | 0.080 |
Why?
|
| Vasopressins | 1 | 1991 | 355 | 0.080 |
Why?
|
| Nalbuphine | 1 | 1989 | 20 | 0.080 |
Why?
|
| Lasers | 2 | 2011 | 952 | 0.080 |
Why?
|
| Morphinans | 1 | 1989 | 27 | 0.080 |
Why?
|
| Pupil | 2 | 1991 | 141 | 0.080 |
Why?
|
| Naphthalenes | 1 | 1989 | 198 | 0.080 |
Why?
|
| Fluoresceins | 3 | 1996 | 234 | 0.080 |
Why?
|
| Wet Macular Degeneration | 1 | 2011 | 162 | 0.080 |
Why?
|
| Sclera | 3 | 1995 | 190 | 0.080 |
Why?
|
| Cell Line | 6 | 2006 | 15620 | 0.080 |
Why?
|
| Hydrogen Peroxide | 1 | 2011 | 732 | 0.070 |
Why?
|
| Diabetes Mellitus | 1 | 2005 | 5889 | 0.070 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 1989 | 364 | 0.070 |
Why?
|
| Oxytocin | 1 | 1991 | 401 | 0.070 |
Why?
|
| Depression, Chemical | 2 | 2003 | 185 | 0.070 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2007 | 222 | 0.070 |
Why?
|
| Hemodynamics | 2 | 1991 | 4174 | 0.070 |
Why?
|
| Neuropeptides | 1 | 1992 | 943 | 0.070 |
Why?
|
| Glycocholic Acid | 1 | 2005 | 3 | 0.070 |
Why?
|
| Fusidic Acid | 1 | 2005 | 15 | 0.070 |
Why?
|
| Time Factors | 11 | 2005 | 40165 | 0.060 |
Why?
|
| Cataract | 1 | 1992 | 827 | 0.060 |
Why?
|
| Fentanyl | 1 | 1989 | 434 | 0.060 |
Why?
|
| Male | 28 | 2007 | 359744 | 0.060 |
Why?
|
| Catheterization, Peripheral | 1 | 1989 | 345 | 0.060 |
Why?
|
| Cell Survival | 3 | 2003 | 5797 | 0.060 |
Why?
|
| Oxygenases | 1 | 1985 | 59 | 0.060 |
Why?
|
| Hydrogenation | 1 | 2004 | 20 | 0.060 |
Why?
|
| Trimethaphan | 2 | 1995 | 11 | 0.060 |
Why?
|
| Hemicholinium 3 | 2 | 1995 | 8 | 0.060 |
Why?
|
| Hexamethonium | 2 | 1995 | 17 | 0.060 |
Why?
|
| Scopolamine | 1 | 2005 | 94 | 0.060 |
Why?
|
| Dopamine | 3 | 1993 | 1595 | 0.060 |
Why?
|
| Dextrans | 1 | 2007 | 574 | 0.060 |
Why?
|
| Specific Pathogen-Free Organisms | 2 | 1995 | 220 | 0.060 |
Why?
|
| Muscle Relaxation | 2 | 2001 | 138 | 0.060 |
Why?
|
| Pharmacology | 1 | 2004 | 99 | 0.060 |
Why?
|
| Dinoprostone | 4 | 1995 | 598 | 0.060 |
Why?
|
| Fluorescein | 2 | 1996 | 174 | 0.060 |
Why?
|
| Butyrophenones | 3 | 1992 | 15 | 0.060 |
Why?
|
| Epinephrine | 1 | 1988 | 791 | 0.060 |
Why?
|
| Inflammation | 3 | 2000 | 10756 | 0.060 |
Why?
|
| Sympathetic Nervous System | 1 | 1987 | 520 | 0.060 |
Why?
|
| Amidines | 1 | 2003 | 29 | 0.060 |
Why?
|
| Thiourea | 1 | 2003 | 68 | 0.050 |
Why?
|
| Lipoxygenase | 2 | 1995 | 72 | 0.050 |
Why?
|
| Methylprednisolone | 2 | 1995 | 384 | 0.050 |
Why?
|
| Capillary Permeability | 1 | 2007 | 768 | 0.050 |
Why?
|
| Nitrites | 1 | 2003 | 159 | 0.050 |
Why?
|
| Receptors, Dopamine | 1 | 1984 | 292 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 1996 | 4166 | 0.050 |
Why?
|
| Colorimetry | 1 | 2003 | 153 | 0.050 |
Why?
|
| Adenosine | 1 | 1988 | 834 | 0.050 |
Why?
|
| Detergents | 2 | 1995 | 235 | 0.050 |
Why?
|
| Dogs | 5 | 2005 | 3841 | 0.050 |
Why?
|
| Benzylamines | 1 | 2003 | 248 | 0.050 |
Why?
|
| Algorithms | 1 | 2003 | 13981 | 0.050 |
Why?
|
| Arachidonic Acids | 2 | 1997 | 294 | 0.050 |
Why?
|
| Nitrates | 1 | 2003 | 264 | 0.050 |
Why?
|
| Brain Ischemia | 1 | 1995 | 3127 | 0.050 |
Why?
|
| Injections | 2 | 1995 | 830 | 0.050 |
Why?
|
| Aging | 3 | 2005 | 8651 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1992 | 3765 | 0.050 |
Why?
|
| Quinolizines | 3 | 1991 | 21 | 0.050 |
Why?
|
| Reserpine | 2 | 1996 | 60 | 0.050 |
Why?
|
| Optic Neuropathy, Ischemic | 1 | 2002 | 86 | 0.050 |
Why?
|
| Cell Line, Transformed | 1 | 2002 | 869 | 0.050 |
Why?
|
| Biological Availability | 2 | 1993 | 395 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2003 | 1744 | 0.050 |
Why?
|
| Drug Interactions | 1 | 2005 | 1428 | 0.050 |
Why?
|
| Excipients | 2 | 1992 | 97 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2001 | 174 | 0.050 |
Why?
|
| Pharmaceutical Preparations | 1 | 1989 | 1091 | 0.040 |
Why?
|
| Guinea Pigs | 3 | 1991 | 1316 | 0.040 |
Why?
|
| Quality Control | 1 | 2003 | 828 | 0.040 |
Why?
|
| Sympathomimetics | 2 | 1993 | 56 | 0.040 |
Why?
|
| Lethal Dose 50 | 1 | 1999 | 72 | 0.040 |
Why?
|
| Permeability | 2 | 1992 | 719 | 0.040 |
Why?
|
| Glucose | 2 | 1992 | 4351 | 0.040 |
Why?
|
| Ocular Physiological Phenomena | 1 | 1999 | 67 | 0.040 |
Why?
|
| Taxoids | 1 | 2002 | 669 | 0.040 |
Why?
|
| Cerebral Cortex | 1 | 1995 | 5761 | 0.040 |
Why?
|
| Cell Count | 1 | 2003 | 1835 | 0.040 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2003 | 741 | 0.040 |
Why?
|
| History, 21st Century | 1 | 2004 | 1575 | 0.040 |
Why?
|
| Ophthalmology | 1 | 2004 | 549 | 0.040 |
Why?
|
| Cell Culture Techniques | 2 | 2003 | 1664 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2001 | 704 | 0.040 |
Why?
|
| Frontal Lobe | 1 | 2004 | 1420 | 0.040 |
Why?
|
| Pilocarpine | 2 | 1989 | 64 | 0.040 |
Why?
|
| Phantoms, Imaging | 2 | 2003 | 2512 | 0.040 |
Why?
|
| S-Nitrosoglutathione | 1 | 1997 | 23 | 0.040 |
Why?
|
| Dinoprost | 2 | 1991 | 138 | 0.040 |
Why?
|
| Water | 1 | 2003 | 1407 | 0.040 |
Why?
|
| Publishing | 1 | 2004 | 836 | 0.040 |
Why?
|
| Biological Transport, Active | 1 | 1997 | 327 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 2001 | 1792 | 0.030 |
Why?
|
| Veins | 2 | 1993 | 765 | 0.030 |
Why?
|
| Vasodilation | 1 | 2000 | 962 | 0.030 |
Why?
|
| p-Hydroxyamphetamine | 1 | 1996 | 3 | 0.030 |
Why?
|
| History, 20th Century | 1 | 2004 | 2773 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2006 | 2145 | 0.030 |
Why?
|
| Acetophenones | 1 | 1996 | 53 | 0.030 |
Why?
|
| Surgical Flaps | 2 | 1995 | 1669 | 0.030 |
Why?
|
| Muscle Contraction | 1 | 2001 | 1201 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2003 | 5039 | 0.030 |
Why?
|
| Histamine | 1 | 1997 | 498 | 0.030 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2003 | 1489 | 0.030 |
Why?
|
| Intracellular Fluid | 1 | 1995 | 201 | 0.030 |
Why?
|
| Pralidoxime Compounds | 1 | 1995 | 5 | 0.030 |
Why?
|
| Cholinesterase Reactivators | 1 | 1995 | 6 | 0.030 |
Why?
|
| Forecasting | 1 | 2004 | 2932 | 0.030 |
Why?
|
| Potassium Chloride | 1 | 1995 | 230 | 0.030 |
Why?
|
| Aqueous Humor | 3 | 1991 | 153 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 2 | 1995 | 1796 | 0.030 |
Why?
|
| Paclitaxel | 1 | 2002 | 1736 | 0.030 |
Why?
|
| Cerebrovascular Circulation | 1 | 2005 | 2733 | 0.030 |
Why?
|
| Random Allocation | 1 | 1999 | 2394 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2005 | 36290 | 0.030 |
Why?
|
| Embryo, Mammalian | 2 | 1997 | 1674 | 0.030 |
Why?
|
| Hexamethonium Compounds | 1 | 1994 | 23 | 0.030 |
Why?
|
| Complement Hemolytic Activity Assay | 1 | 1994 | 9 | 0.030 |
Why?
|
| Mecamylamine | 1 | 1994 | 27 | 0.030 |
Why?
|
| Photic Stimulation | 1 | 2000 | 1967 | 0.030 |
Why?
|
| Aorta, Thoracic | 2 | 1997 | 1097 | 0.030 |
Why?
|
| Corneal Diseases | 1 | 2000 | 536 | 0.030 |
Why?
|
| Cognition Disorders | 2 | 2005 | 3976 | 0.030 |
Why?
|
| Acetyltransferases | 2 | 1985 | 231 | 0.030 |
Why?
|
| Feasibility Studies | 2 | 1995 | 5201 | 0.030 |
Why?
|
| Cats | 2 | 1986 | 976 | 0.030 |
Why?
|
| Phenazocine | 1 | 1993 | 7 | 0.030 |
Why?
|
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 1993 | 19 | 0.030 |
Why?
|
| Parasympathomimetics | 1 | 1993 | 27 | 0.030 |
Why?
|
| 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer | 1 | 1993 | 20 | 0.030 |
Why?
|
| Plants, Medicinal | 1 | 1994 | 166 | 0.030 |
Why?
|
| Xylazine | 1 | 1993 | 12 | 0.030 |
Why?
|
| Spiperone | 1 | 1992 | 31 | 0.030 |
Why?
|
| Brain | 3 | 2005 | 26951 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2000 | 2105 | 0.030 |
Why?
|
| Humans | 15 | 2006 | 760621 | 0.030 |
Why?
|
| Choline | 1 | 1995 | 513 | 0.030 |
Why?
|
| Anterior Eye Segment | 1 | 1994 | 141 | 0.030 |
Why?
|
| Lipids | 1 | 2003 | 3336 | 0.030 |
Why?
|
| Receptors, Opioid | 1 | 1993 | 145 | 0.030 |
Why?
|
| Leukotrienes | 1 | 1994 | 231 | 0.030 |
Why?
|
| Poisoning | 1 | 1994 | 252 | 0.030 |
Why?
|
| Flavins | 1 | 1992 | 18 | 0.030 |
Why?
|
| Cerebral Ventricles | 2 | 2005 | 542 | 0.030 |
Why?
|
| Tonometry, Ocular | 1 | 1993 | 235 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 1995 | 749 | 0.020 |
Why?
|
| Pulsatile Flow | 1 | 1993 | 321 | 0.020 |
Why?
|
| Metabolic Clearance Rate | 1 | 1992 | 361 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 1995 | 1456 | 0.020 |
Why?
|
| DNA Replication | 1 | 1998 | 1412 | 0.020 |
Why?
|
| Neoplasm Transplantation | 2 | 2002 | 2014 | 0.020 |
Why?
|
| Heart Rate | 3 | 1991 | 4179 | 0.020 |
Why?
|
| Necrosis | 1 | 1995 | 1612 | 0.020 |
Why?
|
| Atrial Natriuretic Factor | 1 | 1992 | 350 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2004 | 3832 | 0.020 |
Why?
|
| Carbon Isotopes | 1 | 1992 | 459 | 0.020 |
Why?
|
| Kinetics | 2 | 1989 | 6377 | 0.020 |
Why?
|
| Pyrrolidines | 1 | 1993 | 340 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 1995 | 1600 | 0.020 |
Why?
|
| RNA, Messenger | 3 | 2000 | 12766 | 0.020 |
Why?
|
| Alloxan | 1 | 1990 | 13 | 0.020 |
Why?
|
| Surface-Active Agents | 1 | 1991 | 150 | 0.020 |
Why?
|
| Receptors, Catecholamine | 1 | 1989 | 6 | 0.020 |
Why?
|
| Antipsychotic Agents | 1 | 1984 | 3061 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 1992 | 575 | 0.020 |
Why?
|
| Mice | 4 | 2003 | 81208 | 0.020 |
Why?
|
| Adjuvants, Pharmaceutic | 1 | 1990 | 49 | 0.020 |
Why?
|
| Lens, Crystalline | 1 | 1992 | 388 | 0.020 |
Why?
|
| Leucyl Aminopeptidase | 1 | 1989 | 12 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 1995 | 1745 | 0.020 |
Why?
|
| Alfentanil | 1 | 1989 | 27 | 0.020 |
Why?
|
| Saponins | 1 | 1989 | 50 | 0.020 |
Why?
|
| Thymidine | 2 | 2000 | 299 | 0.020 |
Why?
|
| Blood Pressure | 3 | 1991 | 8525 | 0.020 |
Why?
|
| Dimethyl Sulfoxide | 1 | 1989 | 252 | 0.020 |
Why?
|
| Uridine | 2 | 2000 | 143 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2005 | 14495 | 0.020 |
Why?
|
| Drug Therapy, Combination | 2 | 1989 | 6498 | 0.020 |
Why?
|
| Drug Evaluation | 1 | 1990 | 641 | 0.020 |
Why?
|
| Models, Biological | 2 | 1995 | 9467 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2000 | 4357 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 1989 | 1142 | 0.020 |
Why?
|
| Papaverine | 1 | 1988 | 45 | 0.020 |
Why?
|
| Dipyridamole | 1 | 1988 | 143 | 0.020 |
Why?
|
| Theophylline | 1 | 1988 | 131 | 0.020 |
Why?
|
| Choline O-Acetyltransferase | 2 | 1985 | 155 | 0.020 |
Why?
|
| Aorta | 1 | 1995 | 2039 | 0.020 |
Why?
|
| Retinal Diseases | 1 | 1994 | 702 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 14660 | 0.020 |
Why?
|
| Myocardial Contraction | 2 | 1984 | 1516 | 0.020 |
Why?
|
| Chickens | 2 | 1987 | 860 | 0.020 |
Why?
|
| Leucine | 2 | 2000 | 547 | 0.020 |
Why?
|
| Mice, Inbred A | 1 | 1987 | 246 | 0.020 |
Why?
|
| Sympathectomy, Chemical | 1 | 1987 | 25 | 0.020 |
Why?
|
| Diamines | 1 | 1987 | 59 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 1995 | 6131 | 0.020 |
Why?
|
| Aspirin | 1 | 1999 | 3364 | 0.020 |
Why?
|
| Ketamine | 1 | 1993 | 516 | 0.020 |
Why?
|
| Half-Life | 1 | 1988 | 652 | 0.020 |
Why?
|
| Mice, Inbred ICR | 1 | 1987 | 364 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2001 | 12427 | 0.020 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 1992 | 1153 | 0.020 |
Why?
|
| Analgesics | 1 | 1993 | 1065 | 0.020 |
Why?
|
| Leukocytes | 1 | 1994 | 2026 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1988 | 2186 | 0.020 |
Why?
|
| 7-Alkoxycoumarin O-Dealkylase | 1 | 1985 | 2 | 0.020 |
Why?
|
| Acetylcholine | 1 | 1987 | 629 | 0.020 |
Why?
|
| Coronary Circulation | 1 | 1991 | 1577 | 0.020 |
Why?
|
| Arylamine N-Acetyltransferase | 1 | 1985 | 86 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2003 | 20080 | 0.010 |
Why?
|
| Carbonic Anhydrase Inhibitors | 1 | 1985 | 91 | 0.010 |
Why?
|
| Saline Solution, Hypertonic | 1 | 1985 | 114 | 0.010 |
Why?
|
| Erythrocytes | 1 | 1994 | 2415 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 1985 | 452 | 0.010 |
Why?
|
| Diagnostic Techniques, Neurological | 1 | 2004 | 62 | 0.010 |
Why?
|
| Laser Therapy | 1 | 1991 | 1089 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1989 | 2502 | 0.010 |
Why?
|
| Binding Sites | 1 | 1993 | 6048 | 0.010 |
Why?
|
| Microcirculation | 1 | 1989 | 1278 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2005 | 8950 | 0.010 |
Why?
|
| Histamine Antagonists | 1 | 1984 | 90 | 0.010 |
Why?
|
| Emulsions | 1 | 2003 | 152 | 0.010 |
Why?
|
| Arachidonic Acid | 1 | 1985 | 433 | 0.010 |
Why?
|
| Prostaglandins F | 1 | 1983 | 80 | 0.010 |
Why?
|
| Drug Delivery Systems | 1 | 1995 | 2221 | 0.010 |
Why?
|
| Prostaglandins E | 1 | 1983 | 169 | 0.010 |
Why?
|
| Discrimination Learning | 1 | 2004 | 278 | 0.010 |
Why?
|
| Azoles | 1 | 2002 | 21 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 1995 | 3610 | 0.010 |
Why?
|
| Cannabinoids | 1 | 1985 | 173 | 0.010 |
Why?
|
| Dietary Carbohydrates | 1 | 1987 | 892 | 0.010 |
Why?
|
| Fluorouracil | 1 | 1987 | 1631 | 0.010 |
Why?
|
| Isomerism | 1 | 1982 | 197 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 2002 | 825 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 1987 | 2221 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1986 | 1347 | 0.010 |
Why?
|
| Reaction Time | 1 | 1987 | 2075 | 0.010 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 1983 | 477 | 0.010 |
Why?
|
| Serotonin | 1 | 1985 | 1040 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 1985 | 2234 | 0.010 |
Why?
|
| Atrophy | 1 | 2005 | 1627 | 0.010 |
Why?
|
| Brain Mapping | 2 | 2005 | 6568 | 0.010 |
Why?
|
| Gadolinium DTPA | 1 | 2002 | 823 | 0.010 |
Why?
|
| Organ Size | 1 | 2004 | 2254 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2005 | 2852 | 0.010 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2002 | 626 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2005 | 3465 | 0.010 |
Why?
|
| Models, Animal | 1 | 2005 | 2117 | 0.010 |
Why?
|
| Gadolinium | 1 | 2002 | 959 | 0.010 |
Why?
|
| Reference Values | 1 | 2005 | 4925 | 0.010 |
Why?
|
| Ryanodine | 1 | 1997 | 46 | 0.010 |
Why?
|
| Hydroquinones | 1 | 1997 | 34 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2004 | 1866 | 0.010 |
Why?
|
| Uracil | 1 | 1998 | 207 | 0.010 |
Why?
|
| Trachea | 1 | 1982 | 1082 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 1987 | 8552 | 0.010 |
Why?
|
| Norepinephrine | 1 | 1997 | 900 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2002 | 3529 | 0.010 |
Why?
|
| Reperfusion | 1 | 1995 | 271 | 0.010 |
Why?
|
| Neoplasms | 1 | 2002 | 22072 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1987 | 5961 | 0.010 |
Why?
|
| Drug Synergism | 1 | 1997 | 1754 | 0.010 |
Why?
|
| Clonixin | 1 | 1991 | 1 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2002 | 4902 | 0.010 |
Why?
|
| Hippocampus | 1 | 2004 | 3738 | 0.010 |
Why?
|
| Radiography | 1 | 2002 | 6965 | 0.010 |
Why?
|
| Benzofurans | 1 | 1991 | 142 | 0.010 |
Why?
|
| Leukotriene B4 | 1 | 1991 | 280 | 0.010 |
Why?
|
| Contrast Media | 1 | 2002 | 5305 | 0.010 |
Why?
|
| Disease Progression | 1 | 2004 | 13502 | 0.000 |
Why?
|
| Adult | 1 | 2001 | 219994 | 0.000 |
Why?
|
| Adenocarcinoma | 1 | 2002 | 6315 | 0.000 |
Why?
|
| Proteins | 1 | 2000 | 6029 | 0.000 |
Why?
|
| Cross-Sectional Studies | 1 | 2005 | 25942 | 0.000 |
Why?
|
| Brain Neoplasms | 1 | 2002 | 8986 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2002 | 65017 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 2002 | 21025 | 0.000 |
Why?
|
| Middle Aged | 1 | 2002 | 220352 | 0.000 |
Why?
|